Vident Investment Advisory’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-10,307
| Closed | -$794K | – | 1285 |
|
|
2022
Q1 | $794K | Sell |
10,307
-456
| -4% | -$35.1K | 0.02% | 786 |
|
|
2021
Q4 | $950K | Buy |
10,763
+293
| +3% | +$25.9K | 0.02% | 726 |
|
|
2021
Q3 | $809K | Sell |
10,470
-628
| -6% | -$48.5K | 0.02% | 747 |
|
|
2021
Q2 | $926K | Buy |
11,098
+320
| +3% | +$26.7K | 0.03% | 675 |
|
|
2021
Q1 | $814K | Buy |
10,778
+472
| +5% | +$35.6K | 0.03% | 667 |
|
|
2020
Q4 | $903K | Buy |
10,306
+3,146
| +44% | +$276K | 0.04% | 567 |
|
|
2020
Q3 | $545K | Buy |
7,160
+1,194
| +20% | +$90.9K | 0.03% | 643 |
|
|
2020
Q2 | $736K | Buy |
+5,966
| New | +$736K | 0.04% | 557 |
|